Related Experiment Video
Updated: Aug 8, 2026

In Vitro Assay to Evaluate the Impact of Immunoregulatory Pathways on HIV-specific CD4 T Cell Effector Function
Published on: October 16, 2013
Antagonistic effect of interferon-gamma on tat-induced transactivation of HIV long terminal repeat
D Emilie1, M C Maillot, J F Nicolas
1Institut National de la Santé et de la Recherche Médicale, Clamart, France.
Insights
Interferon-gamma (IFN-gamma) inhibits human immunodeficiency virus (HIV) replication by blocking viral gene transactivation. This immune signaling molecule antagonizes the tat protein
Area of Science:
- Immunology
- Virology
- Molecular Biology
Background:
- Interferon-gamma (IFN-gamma) is known to inhibit human immunodeficiency virus (HIV) replication in macrophages.
- The precise mechanism and stage of the HIV infectious cycle affected by IFN-gamma remain unclear.
Purpose of the Study:
- To investigate the specific site of action of IFN-gamma on the HIV infectious cycle.
- To determine if IFN-gamma affects the transactivation of the HIV long terminal repeat (LTR) and its interaction with the tat protein.
Main Methods:
- Utilized the HT4LacZ-1 indicator cell line, a CD4+ HeLa cell line containing an HIV LTR-LacZ gene.
- Employed a computer-assisted image analyzer to quantify transactivated foci, transactivation levels, and cell fusion potency after HIV infection.
- Assessed IFN-gamma's effect on tat-induced LTR transactivation using tat expression vectors and cell fusion techniques.
Main Results:
- IFN-gamma significantly reduced the number of transactivated foci by 75% in HIV-infected HT4LacZ-1 cells.
- The remaining foci showed reduced transactivation levels, and infected cell fusion potency was decreased.
- IFN-gamma's inhibitory effect occurred post-HIV entry and was independent of reverse transcription.
- IFN-gamma antagonized tat-induced LTR transactivation, even when tat was supplied exogenously.
Conclusions:
- IFN-gamma inhibits HIV replication by interfering with tat-mediated LTR transactivation, likely by affecting cellular factors interacting with tat.
- These findings suggest a role for IFN-gamma in the establishment of HIV latency, particularly given its elevated levels during HIV infection.
Abstract:
Interferon-gamma (IFN-gamma) has been shown to inhibit human immunodeficiency virus (HIV) replication in macrophages. However, the site of its effect on the HIV infectious cycle is unknown. We show here that IFN-gamma inhibits the transactivation of HIV long terminal repeat (LTR) during viral infection and that it antagonizes tat effect in HT4LacZ-1 cells. HT4LacZ-1 is an indicator CD4+ HeLa cell line for HIV infectivity, because it harbors a HIV LTR-LacZ gene susceptible to transactivation by tat. It was used in combination with a computer-assisted image analyzer to quantify: (i) the number of transactivated foci following HIV infection, (ii) their individual level of transactivation, and (iii) the fusion potency of infected cells. IFN-gamma induced a 75% decrease of the number of transactivated foci following infection of HT4LacZ-1 cells by HIV. The remaining 25% foci still susceptible to transactivation were transactivated at a lower level than in control cultures, and the fusion potency of infected cells was strongly decreased. IFN-gamma acted after HIV entry into the cell and independently of reverse transcription. IFN-gamma antagonized tat-induced LTR transactivation: it inhibited transactivation of HT4LacZ-1 cells when tat was provided either from a SV40-based expression vector of tat or by polyethylene glycol-induced cell fusion with HeLa-tat-III cells. These results suggest that IFN-gamma affects the expression or the activity of cellular factors interacting with tat and that the high level of IFN-gamma production associated with HIV infection plays a role in the establishment of HIV latency.
Related Concept Videos
LTR Retrotransposons
The internal coding region of LTR retrotransposons and their mechanism of transposition closely resembles a...
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
TGF - β Signaling Pathway
Inhibitors of Viral Protein Synthesis
Inhibitors of Virion Maturation and Assembly

